Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Showing 1 to 12 of 8751 entries
Sorted by: Best Match Show Resources per page
Chemotherapy of osteosarcoma [proceedings].

Proceedings of the Royal Society of Medicine

Bleehen NM.
PMID: 1086477
Proc R Soc Med. 1976 Aug;69(8):552.
Free PMC Article

No abstract available.

[Intra- or Postoperative Chemoprophylaxis? (author's transl)].

Langenbecks Archiv fur Chirurgie

Senn HJ.
PMID: 813077
Langenbecks Arch Chir. 1975 Nov;339:85-93. doi: 10.1007/BF01257494.

The surgical cure rates for most operable cancers have remained unchanged over the past few decades despite progress in local treatment and "prophylactic" preor postoperative radiotherapy. Due to the limitations of primary and secondary prophylaxis (prevention and "early" diagnosis),...

Acute erythroid leukemia after cyclophosphamide therapy for multiple myeloma: report of two cases.

Southern medical journal

West WO.
PMID: 1068531
South Med J. 1976 Oct;69(10):1331-2.

The diagnosis of multiple myeloma was made in two white men, aged 55 and 59 years. They were treated with cyclophosphamide for 98 and 44 months respectively. Patient 1 also received a nine-month course of combined therapy with melphalan,...

[Variable behavior of urinary hydroxyproline in breast cancer with osseous metastases].

Quaderni Sclavo di diagnostica clinica e di laboratorio

Polico C, Nascimben O, Maccari F, Fazzin G.
PMID: 757622
Quad Sclavo Diagn. 1978 Dec;14(4):486-93.

Serial estimations of the hydroxyproline (OHP) excretion during chemotherapy were performed in 24 women bearing advanced breast carcinoma with skeletal metastases. There was a significant correlation between sensitivity of the metastases to treatment and OHP content of urine. Many...

Osteosarcoma: state of the art.

Minnesota medicine

Sim FH, Wold LE, Beabout JW, Amadio PC, McDonald DJ.
PMID: 3531801
Minn Med. 1986 Aug;69(8):442-8.

No abstract available.

Salmon calcitonin in the treatment of bone metastases.

International journal of clinical pharmacology research

Serdengeçti S, Serdengeçti K, Derman U, Berkarda B.
PMID: 3721646
Int J Clin Pharmacol Res. 1986;6(2):151-5.

The effects of salmon calcitonin administered 100 IU i.m. daily for 30 consecutive days were evaluated in patients with painful bone metastasis secondary to different types of solid cancer. The results were compared with placebo-receiving patients. In the 22...

Primary malignant tumours of bone.

British medical journal

Sweetnam R.
PMID: 1069599
Br Med J. 1976 Dec 04;2(6048):1367-9. doi: 10.1136/bmj.2.6048.1367.
Free PMC Article

No abstract available.

Progress in the treatment of osteogenic sarcoma.

Arizona medicine

Lloyd RC.
PMID: 1054563
Ariz Med. 1975 Apr;32(4):341-4.

No abstract available.

[Biphosphonates. Contribution to the treatment of malignant osteolysis].

Presse medicale (Paris, France : 1983)

Prier A.
PMID: 1409460
Presse Med. 1992 Jul 4-11;21(25):1143-5.

No abstract available.

[Criteria, types and symptoms of local cure of radiosensitive malignant bone tumors in the course of radiotherapy].


Zomer-Drozda J, Buraczewski J.
PMID: 1019045
Nowotwory. 1976;119-28.

No abstract available.

"Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.

Cancer treatment reports

Von Hoff DD, Rozencweig M, Louie AC, Bender RA, Muggia FM.
PMID: 305823
Cancer Treat Rep. 1978 Feb;62(2):233-5.

No abstract available.

Phase II trial of Baker's antifol in metastatic sarcoma.

Cancer treatment reports

Thigpen JT, O'Bryan RM, Benjamin RS, Coltman CA.
PMID: 922752
Cancer Treat Rep. 1977 Nov;61(8):1485-7.

Iv Baker's antifol (BAF) (250 mg/m2/day X 3 consecutive days) was administered to 34 patients with metastatic sarcoma. All patients had received extensive prior therapy including prior chemotherapy and had progressive disease at the start of the study. Liver...

Showing 1 to 12 of 8751 entries